- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Diabetes mellitus
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2013 PBAC Meeting - Word
Insulin degludec – March 2013
Insulin degludec, injection solution, 100 IU/mL and 200 IU/mL, Tresiba Flextouch® and Tresiba Penfill®
Last updated
6 April 2018